David Joseph Hamilton, MD | |
2325 18th St, Suite 130, Columbus, IN 47201-5387 | |
(812) 379-2020 | |
(812) 378-8267 |
Full Name | David Joseph Hamilton |
---|---|
Gender | Male |
Speciality | Internal Medicine - Cardiovascular Disease |
Location | 2325 18th St, Columbus, Indiana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194894675 | NPI | - | NPPES |
000000088173 | Other | IN | ANTHEM BCBS |
100343080 | Medicaid | IN | |
010272P | Other | IN | SIHO |
64756570 | Other | KY | KENTUCKY MEDICAID |
000000984926 | Other | IN | ANTHEM PIN |
060011064 | Other | PALMETTA GBA RAILROAD MC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 01033574A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
David Joseph Hamilton, MD Po Box 775383, Chicago, IL 60677-5383 Ph: (812) 375-3000 | David Joseph Hamilton, MD 2325 18th St, Suite 130, Columbus, IN 47201-5387 Ph: (812) 379-2020 |
News Archive
A condition of publishing in the Open Access life sciences journal F1000Research is that authors make the data underlying their findings publicly available alongside the article. Openly sharing data is an important step in helping tackle issues around the lack of reproducibility of much published research, as well as enabling data reuse.
"Treating a yellow fever patient is reliant on having the right diagnosis. This is dependent on having the necessary laboratory capacity to quickly identify the disease," says Dr Pierre Formenty, an expert in haemorrhagic fevers at WHO and Manager of the Emerging Dangerous Pathogens Laboratory Network.
A research team from the Massachusetts Institute of Technology (MIT)-Harvard Center for Nanotechnology Excellence has custom-designed nanoparticles that can deliver the anticancer drug cisplatin specifically to prostate cancer cells.
Climbers of high peaks such as Mount Kilimanjaro are at high risk for Acute Mountain Sickness (AMS). Trekkers should not ignore AMS warning signs, which can progress to more serious medical outcomes.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has completed the sale of $40 million of Series A Convertible Preferred Stock and warrants to purchase Series A Preferred to a group of institutional investors, including both existing and new investors, in a private placement.
› Verified 8 days ago
Melissa Andrea Martinez Mateo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2326 18th St Ste 210, Columbus, IN 47201 Phone: 812-372-8680 | |
Vatsal Bajpai, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2325 18th St Ste 130, Columbus, IN 47201 Phone: 812-379-2020 | |
Neil Amin, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-376-5974 | |
Dr. Nandu Gourineni, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2325 18th St Ste 130, Columbus, IN 47201 Phone: 812-379-2020 Fax: 812-378-8267 | |
Lawrence Klein, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2325 18th St Ste 130, Columbus, IN 47201 Phone: 812-379-2020 Fax: 812-378-8267 | |
Chelsie Lynn Brady, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-376-5974 Fax: 812-375-3203 | |
Brian M Kline, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 815 Schnier St, Columbus, IN 47201 Phone: 912-375-8810 |